Online ISSN: 2331-4737
www.oncoscience.us
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

LEARN MORE ABOUT ONCOSCIENCE

Therapeutic Opportunities for Hypermutated Urothelial Carcinomas Beyond Immunotherapy

News

May 10, 2024
PRESS RELEASE: On April 25, 2024, a new editorial was published in Oncoscience, entitled, “Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy.” continue reading »

Exploring Oncogenic Driver Molecular Alterations in Hispanic/Latin American Cancer Patients

News

May 3, 2024
PRESS RELEASE: A new editorial paper was published in Oncoscience on April 22, 2024, entitled, “Exploring oncogenic driver molecular alterations in Hispanic/Latin American cancer patients: A call for enhanced molecular understanding.” continue reading »

A Very Long, Winding Road: Developing Novel Therapeutics for Metastatic Tumors

News

February 23, 2024
PRESS RELEASE: On February 9, 2024, a new editorial was published in Oncoscience, entitled, “A very long and winding road: developing novel therapeutics for metastatic tumors.” continue reading »

IPIAD: An Augmentation to Standard Treatment of PDAC Using Five Repurposed Drugs

News

February 9, 2024
PRESS RELEASE: On February 7, 2024, a new research perspective was published in Oncoscience, entitled, “IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone.” continue reading »